Jan 26, 2022

| Technavio News provided by Share this article Share this article NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The demand for molecular biology enzymes, kits, and reagents is increasing continuously among end-users. Hospitals, diagnostic centers, academic institutes, and research organizations extensively use molecular biology kits that include enzymes and reagents for disease diagnosis. Attractive Opportunities in Molecular Biology Enzymes, Kits, and Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025 The advent of molecular technologies and the development of genomics have significantly increased the demand for molecular biology consumables at the genomic level. Also, the increasing use of molecular biology kits in the identification of disease-related genes and management of infectious diseases will positively influence market growth. Key Molecular Biology Enzymes, Kits, and Reagents Market Report Highlights: Market growth 2020-2025: USD 13.09 billion Growth momentum & CAGR: Accelerate at a CAGR of 14.61% YoY growth (%): 14.30% Key consumer countries: China, the US, Germany, the UK, and India Regional Market Analysis With 39% of the growth originating from North America, this region will record a faster growth rate during 2020-2025. The presence of a large number of players and increasing investments in the field of biotechnology are driving the growth of the molecular biology enzymes, kits, and reagents market in North America. The market growth in the region will be slower than the growth of the market in Asia. The US is the key market for molecular biology enzymes, kits, and reagents in North America. Key Vendors and Vendor Strategies Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. are some of the dominant players in the molecular biology enzymes, kits, and reagents market. The molecular biology enzymes, kits, and reagents market is fragmented due to the presence of a large number of players. The vendors in the market are constantly adopting various organic and inorganic growth strategies to remain competitive in the market. Some vendors are focusing on forming strategic alliances or acquiring other players in the market to remain competitive. Agilent Technologies Inc.: The company offers polymerase chain reaction (PCR) enzymes and reagents, inhibitors, and kits for various applications such as reverse transcriptase cloning, cDNA from an RNA template, and high-fidelity cloning. F. Hoffmann-La Roche Ltd.: The company offers a range of molecular biology enzymes, kits, and reagents under its subsidiary Kapa Biosystems, Inc. Illumina Inc.: The company offers a range of common molecular biology reagents such as ribosomal RNA removal reagents, DNA/RNA extraction kits, PCR reagents, and others. Download our free sample report  to get a brief understanding of various vendors and their strategies. Key Market Drivers Our analysts have extensively outlined the information on the key market drivers and their impact on the molecular biology enzymes, kits, and reagents market. Increased use of proteins and reagents in biotechnology and pharmaceutical companies: Pharmaceutical companies are increasing the use of proteins and reagents in the development of drugs for rare genetic disorders and diseases. For example, pharma companies are using glucose oxidase enzymes to detect the amount of glucose in the blood as an indicator for the diagnosis of diabetes. The increasing use of proteins and reagents in many such applications is expected to drive the growth of the market during the forecast period. To know about a few other market drivers, trends, and challenges, Companies profiled Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact